International Conference on Diabetes, Endocrine, and Metabolic Disease Translational Research - (ICDEMDTR-27)


17th - 18th June, 2027 | Stara Zagora, Bulgaria

Multi-format (In-person/Virtual)

Registration Options

Explore conference registration categories designed for every mode of participation.

Important Dates

Pre-registration Deadline

18th May, 2027

Paper Submission Deadline

23rd May, 2027

Last Date Of Registration

2nd June, 2027

Date Of Conference

17th - 18th June, 2027

Downloads

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 2 SDG 2 — Zero Hunger
SDG 3 SDG 3 — Good Health and Well-being
SDG 4 SDG 4 — Quality Education
SDG 9 SDG 9 — Industry, Innovation and Infrastructure
Explore

All Session Tracks

Track 01
Advancements in Adipose Tissue Metabolism

This session will explore the latest research on adipose tissue metabolism and its implications for obesity and diabetes. Presentations will focus on the cellular mechanisms and metabolic pathways involved in adipose tissue function.

Track 02
Gene and Cell Therapies for Metabolic Disorders

This track will discuss innovative gene and cell therapies aimed at treating inherited metabolic disorders. Researchers will present their findings on the efficacy and safety of these novel therapeutic approaches.

Track 03
Immunometabolism and Its Role in Diabetes

This session will delve into the intersection of immunology and metabolism, particularly how immune responses influence diabetes pathogenesis. Presenters will highlight recent discoveries linking inflammation to metabolic dysregulation.

Track 04
Nutrition and Metabolic Responses

This track will examine the impact of dietary patterns on metabolic health and disease outcomes. Experts will discuss the role of nutrition in managing diabetes and other metabolic disorders.

Track 05
Mitochondrial Dysfunction in Metabolic Diseases

This session will focus on the role of mitochondrial dysfunction in various metabolic diseases, including diabetes and obesity. Researchers will present findings on how mitochondrial health affects energy metabolism and disease progression.

Track 06
Innovations in Cardiometabolic Disease Management

This track will highlight cutting-edge strategies for managing cardiometabolic diseases, including diabetes and cardiovascular disorders. Presentations will cover both pharmacological and lifestyle interventions.

Track 07
Genetic Insights into Metabolic Syndrome

This session will explore the genetic factors contributing to metabolic syndrome and its components. Researchers will present data on gene-environment interactions and their implications for disease prevention.

Track 08
Lysosomal Storage Disorders: Diagnosis and Treatment

This track will focus on advancements in the diagnosis and treatment of lysosomal storage disorders. Experts will discuss the role of tandem mass spectrometry and emerging therapies in improving patient outcomes.

Track 09
Obesity and Its Metabolic Consequences

This session will examine the complex relationship between obesity and metabolic diseases, including diabetes and cardiovascular disorders. Researchers will present findings on the mechanisms linking obesity to metabolic dysregulation.

Track 10
Endocrine Disorders and Metabolic Health

This track will explore the interplay between endocrine disorders and metabolic health, focusing on conditions such as thyroid dysfunction and adrenal disorders. Presentations will highlight the impact of hormonal imbalances on metabolism.

Track 11
Emerging Therapies in Diabetes and Metabolism

This session will showcase novel therapeutic approaches for diabetes and metabolic disorders, including new pharmacological agents and lifestyle interventions. Researchers will discuss the potential of these therapies to transform patient care.